Dairy cow mastitis is a serious disease that is mainly caused by intramammary infection with and [group B streptococcus (GBS)]. FnBP and ClfA are the virulence factors of , while GapC is the respective factor for . Sip is a highly immunogenic protein, and it is conserved in all GBS serotypes. In this study, we analyzed the abovementioned four genes prepared a FnBP+ClfA chimeric protein (FC), a GapC+Sip chimeric protein (GS), and a FnBP+ClfA+GapC+Sip chimeric protein (FCGS) based on the antigenic sites to evaluate their use in vaccine development. After expression and purification of the recombinant proteins in , BALB/c mice were immunized with them to examine resistance effects. The total lethal and half lethal doses of and were then measured, and the immunoprotective effects of the fusion proteins were evaluated. The FC and FCGS chimeric proteins could induce mice to produce high levels of antibodies, and bacterial loads were significantly reduced in the spleens and livers after challenge. After immunization with FCGS, the recipients resisted the attacks of both and , indicating the potential of the fusion protein as a mastitis vaccine.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263938 | PMC |
http://dx.doi.org/10.3389/fvets.2021.666098 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!